Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been given an average rating of “Reduce” by the fourteen research firms that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $159.62.
A number of brokerages recently issued reports on CLX. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Barclays boosted their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Finally, Evercore ISI boosted their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th.
Get Our Latest Analysis on Clorox
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the business earned $2.16 earnings per share. Research analysts predict that Clorox will post 7.15 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.35%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC raised its position in Clorox by 7.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 49,141 shares of the company’s stock worth $7,981,000 after acquiring an additional 3,364 shares in the last quarter. Capstone Triton Financial Group LLC raised its position in Clorox by 4.5% in the fourth quarter. Capstone Triton Financial Group LLC now owns 6,213 shares of the company’s stock worth $1,009,000 after acquiring an additional 268 shares in the last quarter. Wood Tarver Financial Group LLC purchased a new position in Clorox in the fourth quarter worth $31,000. Smith Shellnut Wilson LLC ADV raised its position in Clorox by 3.0% in the fourth quarter. Smith Shellnut Wilson LLC ADV now owns 4,375 shares of the company’s stock worth $711,000 after acquiring an additional 127 shares in the last quarter. Finally, Siemens Fonds Invest GmbH grew its holdings in Clorox by 584.8% in the fourth quarter. Siemens Fonds Invest GmbH now owns 8,895 shares of the company’s stock valued at $1,445,000 after purchasing an additional 7,596 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Consumer Discretionary Stocks Explained
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Airline Stocks – Top Airline Stocks to Buy Now
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.